NO20043951L - 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler - Google Patents

3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler

Info

Publication number: NO20043951L
Authority: NO; Norway
Prior art keywords: antibacterial agents; formula; cyclyl; nitrogen; membered ring
Prior art date: 2002-02-28

Application number

NO20043951A

Other languages

English (en)

Norwegian (no)

Other versions

NO20043951D0 (no

Inventor

Michael Barry Gravestock

Neil James Hales

Folkert Reck

Fei Zhou

Paul Robert Fleming

Daniel Robert Carcanague

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-28

Filing date

2004-09-21

Publication date

2004-11-11

2004-09-21 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-09-21 Publication of NO20043951D0 publication Critical patent/NO20043951D0/no

2004-11-11 Publication of NO20043951L publication Critical patent/NO20043951L/no

Links

239000003242 anti bacterial agent Substances 0.000 title abstract 2
VWIIJDNADIEEDB-UHFFFAOYSA-N 3-methyl-1,3-oxazolidin-2-one Chemical class CN1CCOC1=O VWIIJDNADIEEDB-UHFFFAOYSA-N 0.000 title 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 title 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20043951A 2002-02-28 2004-09-21 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler NO20043951L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36068802P	2002-02-28	2002-02-28
PCT/GB2003/000791 WO2003072576A2 (fr)	2002-02-28	2003-02-25	Composes chimiques

Publications (2)

Publication Number	Publication Date
NO20043951D0 NO20043951D0 (no)	2004-09-21
NO20043951L true NO20043951L (no)	2004-11-11

Family

ID=27766238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043951A NO20043951L (no)	2002-02-28	2004-09-21	3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler

Country Status (20)

Country	Link
US (1)	US7199143B2 (fr)
EP (1)	EP1480975A2 (fr)
JP (1)	JP2005531504A (fr)
KR (1)	KR20040086465A (fr)
CN (1)	CN1653064A (fr)
AR (1)	AR039559A1 (fr)
AU (1)	AU2003209994A1 (fr)
BR (1)	BR0308018A (fr)
CA (1)	CA2477379A1 (fr)
CO (1)	CO5601010A2 (fr)
IL (1)	IL163643A0 (fr)
IS (1)	IS7424A (fr)
MX (1)	MXPA04008273A (fr)
NO (1)	NO20043951L (fr)
NZ (1)	NZ535591A (fr)
PL (1)	PL372090A1 (fr)
RU (1)	RU2004129278A (fr)
TW (1)	TW200403241A (fr)
WO (1)	WO2003072576A2 (fr)
ZA (1)	ZA200406684B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002329393B2 (en)	2001-09-11	2008-06-12	Astrazeneca Ab	Oxazolidinone and/or isoxazoline as antibacterial agents
JP2005512975A (ja)	2001-10-25	2005-05-12	アストラゼネカアクチボラグ	抗菌薬として有用なイソキサゾリン誘導体
NZ535592A (en) *	2002-02-28	2006-07-28	Astrazeneca Ab	3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
US7091196B2 (en) *	2002-09-26	2006-08-15	Rib-X Pharmaceuticals, Inc.	Bifunctional heterocyclic compounds and methods of making and using same
CA2507628A1 (fr)	2002-11-28	2004-06-10	Astrazeneca Ab	Composes chimiques
GB0306358D0 (en)	2003-03-20	2003-04-23	Astrazeneca Ab	Chemical compounds
WO2005042523A1 (fr) *	2003-11-03	2005-05-12	Il-Dong Pharm. Co., Ltd.	Nouveau derive d'oxazolidinone et son procede de production
KR100854211B1 (ko)	2003-12-18	2008-08-26	동아제약주식회사	신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CA2610978A1 (fr)	2005-06-29	2007-01-04	Pharmacia & Upjohn Company Llc	Oxazolidinones d'homomorpholine en tant qu'agents antibacteriens
US8084477B2 (en)	2007-10-31	2011-12-27	Bristol-Myers Squibb Company	Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
RU2659792C1 (ru)	2008-10-10	2018-07-04	Мерк Шарп Энд Домэ Корп.	Оксазолидиноны и способ их очистки
MX384300B (es)	2009-02-03	2025-03-14	Merck Sharp & Dohme Llc	Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona.
US8580767B2 (en)	2009-05-28	2013-11-12	Trius Therapeutics, Inc.	Oxazolidinone containing dimer compounds, compositions and methods to make and use
CN101792437B (zh) *	2010-03-10	2012-01-25	天津药物研究院	一类三氮唑的衍生物、其制备方法和用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1260948A (fr) *	1984-12-05	1989-09-26	E. I. Du Pont De Nemours And Company	Derives d'aminomethyloxo-oxazolidinylbenzene, agents antibacteriens
MY115155A (en)	1993-09-09	2003-04-30	Upjohn Co	Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE4332384A1 (de) *	1993-09-23	1995-03-30	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten III
GB9521508D0 (en)	1995-10-20	1995-12-20	Zeneca Ltd	Chemical compounds
GB9601666D0 (en)	1996-01-27	1996-03-27	Zeneca Ltd	Chemical compounds
GB9702213D0 (en)	1996-02-24	1997-03-26	Zeneca Ltd	Chemical compounds
GB9604301D0 (en)	1996-02-29	1996-05-01	Zeneca Ltd	Chemical compounds
GB9609919D0 (en)	1996-05-11	1996-07-17	Zeneca Ltd	Chemical compounds
GB9614238D0 (en)	1996-07-06	1996-09-04	Zeneca Ltd	Chemical compounds
GB9614236D0 (en)	1996-07-06	1996-09-04	Zeneca Ltd	Chemical compounds
GB9717804D0 (en)	1997-08-22	1997-10-29	Zeneca Ltd	Chemical compounds
GB9717807D0 (en)	1997-08-22	1997-10-29	Zeneca Ltd	Chemical compounds
JP2001514259A (ja)	1997-08-29	2001-09-11	ゼネカ・リミテッド	アミノメチルオキソオキサゾリジニルベンゼン誘導体
GB9725244D0 (en)	1997-11-29	1998-01-28	Zeneca Ltd	Chemical compounds
GB9812019D0 (en)	1998-06-05	1998-07-29	Zeneca Ltd	Chemical compounds
EP1082323A2 (fr)	1998-06-05	2001-03-14	AstraZeneca UK Limited	Composes chimiques
GB9821938D0 (en)	1998-10-09	1998-12-02	Zeneca Ltd	Chemical compounds
GB9928499D0 (en)	1999-12-03	2000-02-02	Zeneca Ltd	Chemical processes and intermediates
GB9928568D0 (en)	1999-12-03	2000-02-02	Zeneca Ltd	Chemical compounds
ES2248284T3 (es) *	2000-02-10	2006-03-16	PHARMACIA & UPJOHN COMPANY LLC	Oxazolidinontioamidas con sustituyentes piperazinamida.
GB0009803D0 (en) *	2000-04-25	2000-06-07	Astrazeneca Ab	Chemical compounds
US6277868B1 (en) *	2000-08-31	2001-08-21	Abbott Laboratories	Oxazolidinone chemotherapeutic agents
JP3972575B2 (ja)	2000-11-02	2007-09-05	株式会社日立製作所	ドアシステム
GB0108794D0 (en)	2001-04-07	2001-05-30	Astrazeneca Ab	Chemical compound
DE60212959T2 (de)	2001-04-07	2007-02-15	Astrazeneca Ab	Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
GB0108793D0 (en)	2001-04-07	2001-05-30	Astrazeneca Ab	Chemical compounds
GB0108764D0 (en)	2001-04-07	2001-05-30	Astrazeneca Ab	Chemical compounds
GB0113297D0 (en)	2001-06-01	2001-07-25	Astrazeneca Ab	Chemical Process
GB0113299D0 (en)	2001-06-01	2001-07-25	Astrazeneca Ab	Chemical process & intermediates
GB0113300D0 (en)	2001-06-01	2001-07-25	Astrazeneca Ab	Purification process
GB0121490D0 (en)	2001-09-05	2001-10-24	Smithkline Beecham Plc	Ciompounds
AU2002329393B2 (en)	2001-09-11	2008-06-12	Astrazeneca Ab	Oxazolidinone and/or isoxazoline as antibacterial agents
JP2005512975A (ja)	2001-10-25	2005-05-12	アストラゼネカアクチボラグ	抗菌薬として有用なイソキサゾリン誘導体
WO2003035648A1 (fr)	2001-10-25	2003-05-01	Astrazeneca Ab	Oxazolidinones substituees par un groupe aryle presentant une activite antibacterienne
GB0227701D0 (en)	2002-11-28	2003-01-08	Astrazeneca Ab	Chemical compounds
NZ540147A (en)	2002-11-28	2008-03-28	Astrazeneca Ab	Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
CA2507628A1 (fr)	2002-11-28	2004-06-10	Astrazeneca Ab	Composes chimiques
GB0229521D0 (en)	2002-12-19	2003-01-22	Astrazeneca Ab	Chemical compounds
GB0229518D0 (en)	2002-12-19	2003-01-22	Astrazeneca Ab	Chemical compounds
GB0229522D0 (en)	2002-12-19	2003-01-22	Astrazeneca Ab	Chemical compounds
GB0229526D0 (en)	2002-12-19	2003-01-22	Astrazeneca Ab	Chemical compounds
TW200500360A (en)	2003-03-01	2005-01-01	Astrazeneca Ab	Hydroxymethyl compounds
GB0306357D0 (en)	2003-03-20	2003-04-23	Astrazeneca Ab	Chemical compounds
GB0306358D0 (en)	2003-03-20	2003-04-23	Astrazeneca Ab	Chemical compounds

2003
- 2003-02-25 WO PCT/GB2003/000791 patent/WO2003072576A2/fr not_active Ceased
- 2003-02-25 PL PL03372090A patent/PL372090A1/xx not_active Application Discontinuation
- 2003-02-25 RU RU2004129278/04A patent/RU2004129278A/ru not_active Application Discontinuation
- 2003-02-25 JP JP2003571282A patent/JP2005531504A/ja active Pending
- 2003-02-25 CN CNA038091607A patent/CN1653064A/zh active Pending
- 2003-02-25 KR KR10-2004-7013476A patent/KR20040086465A/ko not_active Withdrawn
- 2003-02-25 IL IL16364303A patent/IL163643A0/xx unknown
- 2003-02-25 EP EP03742987A patent/EP1480975A2/fr not_active Withdrawn
- 2003-02-25 CA CA002477379A patent/CA2477379A1/fr not_active Abandoned
- 2003-02-25 AU AU2003209994A patent/AU2003209994A1/en not_active Abandoned
- 2003-02-25 BR BR0308018-8A patent/BR0308018A/pt not_active IP Right Cessation
- 2003-02-25 MX MXPA04008273A patent/MXPA04008273A/es unknown
- 2003-02-25 US US10/505,902 patent/US7199143B2/en not_active Expired - Fee Related
- 2003-02-25 NZ NZ535591A patent/NZ535591A/en unknown
- 2003-02-27 TW TW092104234A patent/TW200403241A/zh unknown
- 2003-02-28 AR ARP030100688A patent/AR039559A1/es unknown
2004
- 2004-08-23 ZA ZA200406684A patent/ZA200406684B/en unknown
- 2004-08-25 CO CO04083219A patent/CO5601010A2/es not_active Application Discontinuation
- 2004-08-26 IS IS7424A patent/IS7424A/is unknown
- 2004-09-21 NO NO20043951A patent/NO20043951L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO5601010A2 (es)	2006-01-31
JP2005531504A (ja)	2005-10-20
RU2004129278A (ru)	2005-06-10
BR0308018A (pt)	2005-01-04
CN1653064A (zh)	2005-08-10
IS7424A (is)	2004-08-26
US7199143B2 (en)	2007-04-03
ZA200406684B (en)	2005-09-21
AU2003209994A1 (en)	2003-09-09
AR039559A1 (es)	2005-02-23
PL372090A1 (en)	2005-07-11
MXPA04008273A (es)	2004-11-10
KR20040086465A (ko)	2004-10-08
US20050182112A1 (en)	2005-08-18
NO20043951D0 (no)	2004-09-21
EP1480975A2 (fr)	2004-12-01
NZ535591A (en)	2006-07-28
WO2003072576A3 (fr)	2003-12-31
IL163643A0 (en)	2005-12-18
CA2477379A1 (fr)	2003-09-04
WO2003072576A2 (fr)	2003-09-04
TW200403241A (en)	2004-03-01

Legal Events

Date	Code	Title	Description
2008-09-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20084382L (no)	2008-11-19	Sykloalkylaminosyrederivater og farmasoytiske sammensetninger derav
MY140528A (en)	2009-12-31	Spiroketal derivatives and their use as therapeutic agents for diabetes
NO20025091L (no)	2002-12-09	Oksazolidinonderivater med antibiotisk aktivitet
NO20085169L (no)	2009-01-20	Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
NO20072371L (no)	2007-07-12	Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
TWI262917B (en)	2006-10-01	2-Furancarboxylic hydrazides and pharmaceutical compositions containing the same
NO20092286L (no)	2009-08-13	Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
MXPA05009205A (es)	2005-10-18	Derivados de dihidroxiisoxasol hidroximetil sustituidos utiles como agentes antibioticos.
NO20074763L (no)	2007-11-16	(1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
NO20053133L (no)	2005-07-15	Kjemiske forbindelser.
NO20072409L (no)	2007-06-11	Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20092689L (no)	2009-09-14	Quinuclidinolderivater som muskarin reseptorantagonister
MXPA03005822A (es)	2004-05-04	Compuestos heterociclicos que tienen actividad antibacteriana, proceso para su preparacion y composiciones farmaceuticas que los contienen.
NO20075617L (no)	2007-12-03	4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet
TW200626553A (en)	2006-08-01	Novel compounds
AU2014259608A1 (en)	2015-11-12	Antimicrobial potentiators
WO2005003087A3 (fr)	2005-03-17	Composes nouveaux utiles comme agents anti-bacteriens
DK1425280T3 (da)	2007-01-02	Kemiske forbindelser
DE69426836D1 (de)	2001-04-12	Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
WO2003072576A3 (fr)	2003-12-31	Composes chimiques
NO20062491L (no)	2006-09-06	Benzoksazinderivter og deres anvendelse
AR007108A1 (es)	1999-10-13	Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
NO20061584L (no)	2006-06-06	Substituerte 2-karbonylamino-6-piperidinaminopyridiner og substituerte 1-karbonylamino-3-piperidinaminobenzener som 5-HT1F agonister
ATE476431T1 (de)	2010-08-15	Piperidin- und azetidinderivate als glyt1- inhibitoren
HUP0303204A2 (hu)	2003-12-29	1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények